Table 2.

Baseline echocardiographic, laboratory and coronary, angiographic findings in patients with versus without cardiovascular risk factors

Variable	Without risk factors (n = 1,420)	With risk factors (n = 9,970)	p value
Echocardiographic finding
LVEF, %	52.2 ± 10.7	52.4 ± 11.1	0.519
LVEF < 40%	162 (11.4)	1,135 (11.4)	0.968
Laboratory finding
Admission glucose, mg/dL	145.2 ± 54.4	171.2 ± 82.5	< 0.001
Admission creatinine, mg/dL	0.9 ± 0.5	1.1 ± 1.2	< 0.001
Peak CK, U/L	1,071.5 ± 2,842.4	1,016.4 ± 1,742.7	0.349
Peak CK-MB, ng/mL	113.7 ± 140.5	113.0 ± 170.3	0.889
Peak troponin I, ng/mL	46.7 ± 136.4	47.7 ± 100.9	0.773
Total cholesterol, mg/dL	184.0 ± 44.3	179.8 ± 46.4	0.002
Triglyceride, mg/dL	104.9 ± 88.4	139.7 ± 126.6	< 0.001
HDL-C, mg/dL	46.5 ±13.6	42.5 ± 12.2	< 0.001
LDL-C, mg/dL	118.6 ± 41.7	113.2 ± 39.7	< 0.001
NT-proBNP, pg/mL	2,447.5 ± 8,523.7	2,496.5 ± 8,198.7	0.867
hs-CRP, mg/dL	1.21 ± 3.4	1.53 ± 6.2	0.141
Coronary angiographic finding
PCI	1,276 (89.9)	9,058 (90.9)	0.123
Successful PCI	1,263 (99.0)	8,960 (98.9)	0.962
No. of involved vessels			< 0.001
Single vessel	725 (51.1)	4,597 (46.1)
Left main or multivessel	607 (42.7)	4,929 (49.4)
Target lesion vessel			0.003
Left anterior descending	669 (47.1)	4,214 (42.3)
Left circumflex	204 (14.4)	1,605 (16.1)
Right coronary	382 (26.9)	3,437 (30.2)
Left main	26 (1.8)	197 (2.0)
ACC/AHA type			0.789
Type A/B1	166 (13.0)	1,370 (13.2)
Type B2/C	1,114 (87.0)	8,980 (86.8)

Values are presented as mean ± SD or number (%).

LVEF, left ventricular ejection fraction; CK, creatine kinase; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; NT-proBNP, N-terminal pro B-type natriuretic peptide; hs-CRP, high-sensitivity C-reactive protein; PCI, percutaneous coronary intervention; ACC/AHA, American College of Cardiology/American Heart Association.